T1	p 197 327	in borderline hypertensive patients with IDDM-type diabetes mellitus . Twenty-nine IDDM patients with borderline hypertension were
T2	p 1474 1522	diabetic patients with borderline hypertension .
T3	i 81 120	dihydropyridine calcium channel blocker
T4	i 154 172	placebo-controlled
T5	i 184 196	nitrendipine
T6	i 350 402	placebo or nitrendipine treatment . Nitrendipine was
T7	i 538 565	non exhausting exercise was
T8	i 778 786	collagen
T9	i 823 842	mM arachidonic acid
T10	i 1015 1022	placebo
T11	i 1151 1162	stimulation
T12	i 1214 1226	nitrendipine
T13	i 1307 1319	nitrendipine
T14	i 1384 1396	nitrendipine
T15	o 14 44	platelet thromboxane formation
T16	o 474 507	platelet thromboxane formation at
T17	o 611 683	plasma levels of platelet factor 4 and aggregation responses to collagen
T18	o 733 754	thromboxane formation
T19	o 838 849	acid ( AA )
T20	o 902 933	change of thromboxane synthesis
T21	o 1052 1069	PF4 plasma levels
T22	o 1118 1135	blood aggregation
T23	o 1268 1279	aggregation
T24	o 1337 1359	platelet rich plasma .
T25	o 1438 1457	platelet activation